Biotech CEOs to FDA: Don’t Let Politics Override Science on Abortion Pill

Biotech CEOs to FDA: Don’t Let Politics Override Science on Abortion Pill

Fifty-three biotechnology industry leaders and investors representing dozens of companies and organizations issued a letter late last month advising the U.S. Food and Drug Administration: Follow the science on mifepristone, not political ideology. The Biotech CEO Sisterhood initiated the letter, with Grace Colón as lead author and dozens of senior biotechnology leaders signed on in support. “We are urging the agency and the department to continu…